{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T03:29:24Z","timestamp":1792726164809,"version":"4.5.0"},"reference-count":46,"publisher":"American Medical Association (AMA)","issue":"8","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA Netw Open"],"abstract":"\n IMPORTANCE<\/jats:title>\n The association between obesity and response to cancer treatment and survival remains unclear, with conflicting findings from various studies. The optimal choice between conventional chemotherapy and immunotherapy for first-line treatment remains uncertain in patients with obesity who potentially have an inadequate therapeutic response to immunotherapy.<\/jats:p>\n <\/jats:sec>\n \n OBJECTIVE<\/jats:title>\n To investigate whether body mass index (BMI) modifies the association of immunotherapy or conventional therapy with overall survival in patients with advanced non\u2013small cell lung cancer (aNSCLC).<\/jats:p>\n <\/jats:sec>\n \n DESIGN, SETTING, and PARTICIPANTS<\/jats:title>\n A retrospective cohort study, using administrative claims data obtained from advanced treatment centers in Japan, was conducted between December 1, 2015, and January 31, 2023. Participants included individuals aged 18 years or older with aNSCLC who received immunotherapy, using immune checkpoint inhibitor (ICI) treatment or conventional chemotherapy.<\/jats:p>\n <\/jats:sec>\n \n EXPOSURE<\/jats:title>\n Immune checkpoint inhibitor therapy as first-line chemotherapy was compared with conventional chemotherapy, identified through patient medical records.<\/jats:p>\n <\/jats:sec>\n \n MAIN OUTCOMES AND MEASURES<\/jats:title>\n The main outcome was overall survival. Survival analysis covered a 3-year follow-up period after the first-line chemotherapy.<\/jats:p>\n <\/jats:sec>\n \n RESULTS<\/jats:title>\n A total of 31\u202f257 patients with aNSCLC were identified. Of these, 12\u202f816 patients received ICI therapy (mean [SD] age, 70.2 [9.1] years; 10\u202f287 [80.3%] men) and 18\u202f441 patients received conventional chemotherapy (mean [SD] age, 70.2 [8.9] years; 14\u202f139 [76.7%] men). Among patients with BMI less than 28, ICI therapy was associated with a significantly lower hazard of mortality (eg, BMI 24: hazard ratio [HR], 0.81; 95% CI, 0.75-0.87) compared with those who underwent conventional chemotherapy. However, no such association was observed among patients with BMI 28 or greater (eg, BMI 28: HR, 0.90; 95% CI, 0.81-1.00).<\/jats:p>\n <\/jats:sec>\n \n CONCLUSIONS AND RELEVANCE<\/jats:title>\n The findings of this retrospective cohort study suggest that BMI modifies the association of ICI therapy compared with conventional chemotherapy with overall survival in patients with aNSCLC. A lack of association between ICI therapy and improved survival in patients with aNSCLC and overweight or obesity compared with conventional chemotherapy was observed. This suggests that ICI therapy may not be the optimal first-line therapy for patients with overweight or obesity and the use of conventional chemotherapy should also be considered in such patients.<\/jats:p>\n <\/jats:sec>","DOI":"10.1001\/jamanetworkopen.2024.25363","type":"journal-article","created":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T11:34:57Z","timestamp":1722598497000},"page":"e2425363","source":"Crossref","is-referenced-by-count":23,"title":["Immunotherapy and Overall Survival Among Patients With Advanced Non\u2013Small Cell Lung Cancer and Obesity"],"prefix":"10.1001","volume":"7","author":[{"given":"Yasutaka","family":"Ihara","sequence":"first","affiliation":[{"name":"Department of Medical Statistics, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Sawa","sequence":"additional","affiliation":[{"name":"Department of Clinical Oncology, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takumi","family":"Imai","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsubasa","family":"Bito","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuki","family":"Shimomura","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryota","family":"Kawai","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayumi","family":"Shintani","sequence":"additional","affiliation":[{"name":"Department of Medical Statistics, Graduate School of Medicine, Osaka Metropolitan University, Osaka, Japan"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","published-online":{"date-parts":[[2024,8,2]]},"reference":[{"issue":"9985","key":"zoi240795r1","doi-asserted-by":"publisher","first-page":"2400","DOI":"10.1016\/S0140-6736(14)61744-X","article-title":"Patchy progress on obesity prevention: emerging examples, entrenched barriers, and new thinking.","volume":"385","author":"Roberto","year":"2015","journal-title":"Lancet"},{"issue":"21","key":"zoi240795r2","doi-asserted-by":"publisher","first-page":"1925","DOI":"10.1016\/j.jacc.2008.12.068","article-title":"Obesity and cardiovascular disease: risk factor, paradox, and impact of weight loss.","volume":"53","author":"Lavie","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"40","key":"zoi240795r3","doi-asserted-by":"publisher","first-page":"2729","DOI":"10.1093\/eurheartj\/ehv414","article-title":"Protective overweight in cardiovascular disease: moving from \u201cparadox\u201d to \u201cparadigm\u201d.","volume":"36","author":"Doehner","year":"2015","journal-title":"Eur Heart J"},{"issue":"1","key":"zoi240795r4","doi-asserted-by":"publisher","first-page":"21","DOI":"10.7326\/0003-4819-144-1-200601030-00006","article-title":"Body mass index and risk for end-stage renal disease.","volume":"144","author":"Hsu","year":"2006","journal-title":"Ann Intern Med"},{"issue":"9612","key":"zoi240795r5","doi-asserted-by":"publisher","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies.","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"key":"zoi240795r6","doi-asserted-by":"publisher","first-page":"1745","DOI":"10.3389\/fimmu.2017.01745","article-title":"Aging, obesity, and inflammatory age-related diseases.","volume":"8","author":"Frasca","year":"2017","journal-title":"Front Immunol"},{"issue":"8","key":"zoi240795r7","doi-asserted-by":"publisher","first-page":"794","DOI":"10.1056\/NEJMsr1606602","article-title":"Body fatness and cancer\u2014viewpoint of the IARC Working Group.","volume":"375","author":"Lauby-Secretan","year":"2016","journal-title":"N Engl J Med"},{"issue":"4","key":"zoi240795r8","doi-asserted-by":"publisher","first-page":"243","DOI":"10.3322\/caac.v62:4","article-title":"Nutrition and physical activity guidelines for cancer survivors.","volume":"62","author":"Rock","year":"2012","journal-title":"CA Cancer J Clin"},{"key":"zoi240795r9","doi-asserted-by":"publisher","first-page":"vi7","DOI":"10.1093\/annonc\/mdt284","article-title":"Primary breast cancer: ESMO clinical practice guidelines for diagnosis, treatment and follow-up.","volume":"24","author":"Senkus","year":"2013","journal-title":"Ann Oncol"},{"issue":"9","key":"zoi240795r10","doi-asserted-by":"publisher","first-page":"56","DOI":"10.1007\/s11912-016-0539-4","article-title":"The obesity paradox in cancer: a review.","volume":"18","author":"Lennon","year":"2016","journal-title":"Curr Oncol Rep"},{"issue":"24","key":"zoi240795r11","doi-asserted-by":"publisher","first-page":"5798","DOI":"10.1002\/cncr.v115:24","article-title":"Effect of comorbidity and body mass index on the survival of African-American and Caucasian patients with colon cancer.","volume":"115","author":"Hines","year":"2009","journal-title":"Cancer"},{"issue":"5","key":"zoi240795r12","doi-asserted-by":"publisher","first-page":"541","DOI":"10.1016\/j.bbmt.2005.12.033","article-title":"Effect of body mass index on mortality of patients with lymphoma undergoing autologous hematopoietic cell transplantation.","volume":"12","author":"Navarro","year":"2006","journal-title":"Biol Blood Marrow Transplant"},{"issue":"4","key":"zoi240795r13","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1016\/j.urology.2006.05.024","article-title":"Greater body mass index is associated with better pathologic features and improved outcome among patients treated surgically for clear cell renal cell carcinoma.","volume":"68","author":"Parker","year":"2006","journal-title":"Urology"},{"issue":"1","key":"zoi240795r14","doi-asserted-by":"publisher","first-page":"89","DOI":"10.1186\/s40425-019-0512-5","article-title":"Complex inter-relationship of body mass index, gender and serum creatinine on survival: exploring the obesity paradox in melanoma patients treated with checkpoint inhibition.","volume":"7","author":"Naik","year":"2019","journal-title":"J Immunother Cancer"},{"issue":"10","key":"zoi240795r15","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0204729","article-title":"Body mass index may predict the response to ipilimumab in metastatic melanoma: an observational multi-centre study.","volume":"13","author":"Richtig","year":"2018","journal-title":"PLoS One"},{"issue":"4","key":"zoi240795r16","doi-asserted-by":"publisher","first-page":"512","DOI":"10.1001\/jamaoncol.2019.5241","article-title":"Association between body mass index and overall survival with immune checkpoint inhibitor therapy for advanced non-small cell lung cancer.","volume":"6","author":"Kichenadasse","year":"2020","journal-title":"JAMA Oncol"},{"issue":"1","key":"zoi240795r17","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1186\/s40425-019-0527-y","article-title":"A multicenter study of body mass index in cancer patients treated with anti-PD-1\/PD-L1 immune checkpoint inhibitors: when overweight becomes favorable.","volume":"7","author":"Cortellini","year":"2019","journal-title":"J Immunother Cancer"},{"issue":"3","key":"zoi240795r18","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1016\/S1470-2045(18)30078-0","article-title":"Association of body-mass index and outcomes in patients with metastatic melanoma treated with targeted therapy, immunotherapy, or chemotherapy: a retrospective, multicohort analysis.","volume":"19","author":"McQuade","year":"2018","journal-title":"Lancet Oncol"},{"issue":"24","key":"zoi240795r19","doi-asserted-by":"publisher","first-page":"1862","DOI":"10.1093\/jnci\/djt310","article-title":"An epidemiologic and genomic investigation into the obesity paradox in renal cell carcinoma.","volume":"105","author":"Hakimi","year":"2013","journal-title":"J Natl Cancer Inst"},{"issue":"1","key":"zoi240795r20","doi-asserted-by":"publisher","first-page":"143","DOI":"10.1007\/s10549-014-2843-8","article-title":"Body fat composition impacts the hematologic toxicities and pharmacokinetics of doxorubicin in Asian breast cancer patients.","volume":"144","author":"Wong","year":"2014","journal-title":"Breast Cancer Res Treat"},{"issue":"3","key":"zoi240795r21","doi-asserted-by":"publisher","first-page":"572","DOI":"10.1073\/pnas.1515472113","article-title":"Revealing the burden of obesity using weight histories.","volume":"113","author":"Stokes","year":"2016","journal-title":"Proc Natl Acad Sci U S A"},{"issue":"9","key":"zoi240795r22","doi-asserted-by":"publisher","first-page":"2263","DOI":"10.1007\/s00125-011-2242-1","article-title":"Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias.","volume":"54","author":"Johnson","year":"2011","journal-title":"Diabetologia"},{"issue":"2","key":"zoi240795r23","doi-asserted-by":"publisher","DOI":"10.1136\/jitc-2020-000725","article-title":"Obesity diminishes response to PD-1-based immunotherapies in renal cancer.","volume":"8","author":"Boi","year":"2020","journal-title":"J Immunother Cancer"},{"issue":"6","key":"zoi240795r24","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1038\/oby.2008.55","article-title":"Visceral fat accumulation induced by a high-fat diet causes the atrophy of mesenteric lymph nodes in obese mice.","volume":"16","author":"Kim","year":"2008","journal-title":"Obesity (Silver Spring)"},{"key":"zoi240795r25","doi-asserted-by":"publisher","DOI":"10.1016\/j.canep.2022.102149","article-title":"Characteristics of patients with lung cancer in clinical practice and their potential eligibility for clinical trials evaluating tyrosine kinase inhibitors or immune checkpoint inhibitors.","volume":"78","author":"van Veelen","year":"2022","journal-title":"Cancer Epidemiol"},{"issue":"2","key":"zoi240795r26","doi-asserted-by":"publisher","first-page":"175","DOI":"10.1007\/s40801-022-00296-5","article-title":"Context and considerations for use of two Japanese real-world databases in Japan: Medical Data Vision and Japanese Medical Data Center.","volume":"9","author":"Laurent","year":"2022","journal-title":"Drugs Real World Outcomes"},{"issue":"2","key":"zoi240795r27","doi-asserted-by":"publisher","first-page":"144","DOI":"10.1016\/j.cllc.2023.11.003","article-title":"Lack of association between immunotherapy and improvement of survival for non\u2013small cell lung cancer patients with hemodialysis: a nationwide retrospective cohort study.","volume":"25","author":"Sawa","year":"2024","journal-title":"Clin Lung Cancer"},{"issue":"12","key":"zoi240795r28","doi-asserted-by":"publisher","first-page":"730","DOI":"10.1007\/s00520-023-08193-5","article-title":"Renin-angiotensin-aldosterone system inhibitors are associated with improved paclitaxel-induced peripheral neuropathy in lung cancer: a study using administrative claims data.","volume":"31","author":"Ihara","year":"2023","journal-title":"Support Care Cancer"},{"issue":"12","key":"zoi240795r30","doi-asserted-by":"publisher","DOI":"10.1001\/jamanetworkopen.2020.29917","article-title":"Lung cancer survival in patients with autoimmune disease.","volume":"3","author":"Jacob","year":"2020","journal-title":"JAMA Netw Open"},{"issue":"11","key":"zoi240795r32","doi-asserted-by":"publisher","first-page":"1245","DOI":"10.1016\/0895-4356(94)90129-5","article-title":"Validation of a combined comorbidity index.","volume":"47","author":"Charlson","year":"1994","journal-title":"J Clin Epidemiol"},{"key":"zoi240795r33","first-page":"61","volume":"14","year":"1965","journal-title":"Md State Med J"},{"issue":"5","key":"zoi240795r36","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1007\/s00262-022-03320-3","article-title":"Nonlinear association between body mass index and overall survival in advanced NSCLC patients treated with immune checkpoint blockade.","volume":"72","author":"Jain","year":"2023","journal-title":"Cancer Immunol Immunother"},{"issue":"3","key":"zoi240795r37","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0118784","article-title":"Obesity triggers enhanced MDSC accumulation in murine renal tumors via elevated local production of CCL2.","volume":"10","author":"Hale","year":"2015","journal-title":"PLoS One"},{"issue":"3","key":"zoi240795r38","doi-asserted-by":"publisher","first-page":"1311","DOI":"10.4049\/jimmunol.1100587","article-title":"Diet-induced obesity alters dendritic cell function in the presence and absence of tumor growth.","volume":"189","author":"James","year":"2012","journal-title":"J Immunol"},{"issue":"1","key":"zoi240795r39","doi-asserted-by":"publisher","first-page":"141","DOI":"10.1038\/s41591-018-0221-5","article-title":"Paradoxical effects of obesity on T cell function during tumor progression and PD-1 checkpoint blockade.","volume":"25","author":"Wang","year":"2019","journal-title":"Nat Med"},{"issue":"6371","key":"zoi240795r40","doi-asserted-by":"publisher","first-page":"104","DOI":"10.1126\/science.aao3290","article-title":"The commensal microbiome is associated with anti-PD-1 efficacy in metastatic melanoma patients.","volume":"359","author":"Matson","year":"2018","journal-title":"Science"},{"issue":"6371","key":"zoi240795r41","doi-asserted-by":"publisher","first-page":"97","DOI":"10.1126\/science.aan4236","article-title":"Gut microbiome modulates response to anti-PD-1 immunotherapy in melanoma patients.","volume":"359","author":"Gopalakrishnan","year":"2018","journal-title":"Science"},{"issue":"4","key":"zoi240795r42","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.ccell.2018.03.015","article-title":"The influence of the gut microbiome on cancer, immunity, and cancer immunotherapy.","volume":"33","author":"Gopalakrishnan","year":"2018","journal-title":"Cancer Cell"},{"key":"zoi240795r43","doi-asserted-by":"publisher","DOI":"10.7554\/eLife.31770","article-title":"Activation of G protein\u2013coupled estrogen receptor signaling inhibits melanoma and improves response to immune checkpoint blockade.","volume":"7","author":"Natale","year":"2018","journal-title":"Elife"},{"issue":"6","key":"zoi240795r44","doi-asserted-by":"publisher","first-page":"737","DOI":"10.1016\/S1470-2045(18)30261-4","article-title":"Cancer immunotherapy efficacy and patients\u2019 sex: a systematic review and meta-analysis.","volume":"19","author":"Conforti","year":"2018","journal-title":"Lancet Oncol"},{"issue":"8","key":"zoi240795r45","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1158\/0008-5472.CAN-17-3287","article-title":"The importance of body composition in explaining the overweight paradox in cancer-counterpoint.","volume":"78","author":"Caan","year":"2018","journal-title":"Cancer Res"},{"issue":"1","key":"zoi240795r46","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1158\/1055-9965.EPI-15-1336","article-title":"Association between body mass index and cancer survival in a pooled analysis of 22 clinical trials.","volume":"26","author":"Greenlee","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"zoi240795r34","first-page":"451","volume-title":"Mice: multivariate imputation by chained equations in R","author":"Buuren","year":"2011"},{"key":"zoi240795r29","unstructured":"Ethical guidelines for medical and health research involving human subjects. Accessed May 24, 2024. https:\/\/www.lifescience.mext.go.jp\/files\/pdf\/n2181_01.pdf"},{"key":"zoi240795r31","unstructured":"World Health Organization. The global health observation, body mass index (BMI). Accessed May 31, 2024. https:\/\/www.who.int\/data\/gho\/data\/themes\/topics\/topic-details\/GHO\/body-mass-index"},{"key":"zoi240795r35","unstructured":"R Core Team. R: a language and environment for statistical computing. R Foundation for Statistical Computing. 2021. Accessed January 31, 2024. https:\/\/www.R-project.org\/"}],"container-title":["JAMA Network Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/articlepdf\/2821877\/ihara_2024_oi_240795_1721926253.93671.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,8,2]],"date-time":"2024-08-02T11:35:08Z","timestamp":1722598508000},"score":1,"resource":{"primary":{"URL":"https:\/\/jamanetwork.com\/journals\/jamanetworkopen\/fullarticle\/2821877"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,8,2]]},"references-count":46,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8,1]]}},"URL":"https:\/\/doi.org\/10.1001\/jamanetworkopen.2024.25363","relation":{},"ISSN":["2574-3805"],"issn-type":[{"value":"2574-3805","type":"electronic"}],"subject":[],"published":{"date-parts":[[2024,8,2]]}}}